Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
CATIS-ICAD is a clinical pilot study in which patients who have had a recent ischemic stroke,
that is a stroke caused by a blood clot or a narrowing of the blood vessels in the brain due
to the build up of plaque, will be randomly assigned to receive either low-dose rivaroxaban +
aspirin or aspirin alone.